Our Portfolio

We help build companies whose breakthroughs will deliver impact on a world-changing scale.

Sanavia’s platform reveals novel biology that tumors use to become inaccessible and invisible to current therapies, allowing the discovery of first-in-class, highly specific and clinically safe targets for diagnosis and treatment of cancer.

Leapfrog Bio has developed a novel high throughput drug screening platform that unlocks the discovery of precision targeting insights for matching patients to small molecular cancer drugs.

Novoron Bioscience is a private biotechnology company developing novel therapeutic approaches to address disorders of the central nervous system (CNS).

Selector’s Usable AIOps is the first analytics solution to provide instant actionable insights to manage multi-domain networks & application delivery infrastructure.

Elisity is helping companies redefine security and access in a world transformed by cloud, mobility, and connected devices.

Graphiant is a Silicon Valley-based stealth mode startup driving the next evolution of computer networking.

The ultra-fast cloud native, interoperable data engine. TileDB Cloud is a serverless solution for data scientists to collaborate and work faster, focusing on their science without engineering hassles.

Innimune is a Montana-based biopharmaceutical company focused on developing novel immunotherapies and vaccines for the treatment of allergy, cancer, infectious disease, and autoimmunity.

Evisioning a world without fraud, Verify is combining world class human expertise from the intellegence community with machine learning technology to disrupt the multi-billion $ / year corporate diligence market.

pulseData develops next generation healthcare solutions powered by artificial intelligence to identify and manage patients at risk for chronic disease, resulting in improved outcomes at a lower cost of care.

Truwl accelerates genome-related advances by providing a common, shared platform for the highly complex workflows, tools, and data that the worldwide medical research community critically depends on.

XIX delivers a platform that helps developers accomplish any AI / computer vision task with just a few lines of code, delivering unmatched accuracy and a 44x cost advantage vs competitors.

FYR Diagnostics’ novel DNA/RNA amplification technology enables dramatically earlier and more precise detection and tracking of the world’s most devastating and burdensome diseases.

CIQ powers the next generation of enterprise high-performance computing with Rocky Linux and a complete infrastructure software stack that integrates workflows, clusters, and the cloud.

CIQ powers the next generation of enterprise high-performance computing with Rocky Linux and a complete infrastructure software stack that integrates workflows, clusters, and the cloud.

Sanavia’s platform reveals novel biology that tumors use to become inaccessible and invisible to current therapies, allowing the discovery of first-in-class, highly specific and clinically safe targets for diagnosis and treatment of cancer.

Leapfrog Bio has developed a novel high throughput drug screening platform that unlocks the discovery of precision targeting insights for matching patients to small molecular cancer drugs.

Novoron Bioscience is a private biotechnology company developing novel therapeutic approaches to address disorders of the central nervous system (CNS).

Selector’s Usable AIOps is the first analytics solution to provide instant actionable insights to manage multi-domain networks & application delivery infrastructure.

Elisity is helping companies redefine security and access in a world transformed by cloud, mobility, and connected devices.

Graphiant is a Silicon Valley-based stealth mode startup driving the next evolution of computer networking.

The ultra-fast cloud native, interoperable data engine. TileDB Cloud is a serverless solution for data scientists to collaborate and work faster, focusing on their science without engineering hassles.

Innimune is a Montana-based biopharmaceutical company focused on developing novel immunotherapies and vaccines for the treatment of allergy, cancer, infectious disease, and autoimmunity.

Evisioning a world without fraud, Verify is combining world class human expertise from the intellegence community with machine learning technology to disrupt the multi-billion $ / year corporate diligence market.

pulseData develops next generation healthcare solutions powered by artificial intelligence to identify and manage patients at risk for chronic disease, resulting in improved outcomes at a lower cost of care.

Truwl accelerates genome-related advances by providing a common, shared platform for the highly complex workflows, tools, and data that the worldwide medical research community critically depends on.

XIX delivers a platform that helps developers accomplish any AI / computer vision task with just a few lines of code, delivering unmatched accuracy and a 44x cost advantage vs competitors.

FYR Diagnostics’ novel DNA/RNA amplification technology enables dramatically earlier and more precise detection and tracking of the world’s most devastating and burdensome diseases.